share_log

Altamira Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Rosalind Advisors, Inc.(8.3%),Steven Salamon(8.3%), etc.

SEC announcement ·  Aug 10, 2018 14:55
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more